Objective
To estimate the utility of umbilical venous lactate, more readily available than umbilcal cord arterial lactate, for predicting arterial lactic acidemia and neonatal outcomes at term.
Methods
This was a prospective cohort study of consecutive, non-anomalous, singleton, term births following labor in a large academic medical center (2009 – 2014). Umbilical arterial and venous lactate were measured immediately after delivery, prior to knowledge of neonatal outcomes. The outcome measures were arterial lactic acidemia (>3.9mmol/L) and a composite neonatal outcome consisting of neonatal death and any of a number of neonatal morbidities including intubation, mechanical ventilation, meconium aspiration syndrome, hypoxic-ischemic encephalopathy, and therapeutic hypothermia. Predictive ability of venous lactate was estimated using the area under the receiver-operating characteristics curve (AUC).
Results
Among 7,741 births, venous lactate was strongly predictive of arterial lactic acidemia (AUC=0.958). The ‘optimal’ cut-point of venous lactate for predicting both arterial lactic acidemia and the composite neonatal outcome was 3.4mmol/L This predicted arterial lactic acidemia with sensitivity of 87.0% and specificity of 91.3%. Positive and negative predictive values were 79.9% and 94.7%, respectively. The composite neonatal outcome occurred in 104 neonates (1.3%). Compared with arterial lactate, venous lactate predicted the composite neonatal outcome with comparable sensitivity (75.0% versus 74.0%, P>0.99), but slightly lower specificity (69.7% versus 72.2%, P<0.01).
Conclusion
Umbilical venous lactate strongly predicts arterial lactic acidemia and is comparable to arterial lactate for predicting neonatal morbidity at term. It could be used as a measure of neonatal morbidity when arterial blood is not available.